Vemurafenib (PLX4032)

For research use only. Not for use in humans.

目录号:S1267 别名: RG7204, RO5185426 中文名称:维罗非尼

Vemurafenib (PLX4032) Chemical Structure

CAS No. 918504-65-1

Vemurafenib (PLX4032, RG7204, RO5185426)是一种新型有效的B-RafV600E抑制剂,IC50为31 nM。Vemurafenib对B-RafV600E的选择性比对野生型B-Raf的选择性高10倍,在细胞实验中,选择性可高100倍以上。Vemurafenib (PLX4032, RG7204) 可诱导自噬。

规格 价格 库存 购买数量  
10mM (1mL in DMSO) RMB 746.23 现货
RMB 567.23 现货
RMB 2213.19 现货
RMB 6308.84 现货
有超大折扣

今日订购,明日送达,全国免运费!

全国免费电话:400-668-6834   |   Email:info@selleck.cn

客户使用Selleck生产的Vemurafenib (PLX4032)发表文献492篇:

产品安全说明书

Raf抑制剂选择性比较

生物活性

产品描述 Vemurafenib (PLX4032, RG7204, RO5185426)是一种新型有效的B-RafV600E抑制剂,IC50为31 nM。Vemurafenib对B-RafV600E的选择性比对野生型B-Raf的选择性高10倍,在细胞实验中,选择性可高100倍以上。Vemurafenib (PLX4032, RG7204) 可诱导自噬。
特性 PLX4032是新型有效的B-RAFV600E 肿瘤蛋白抑制剂。
靶点
SRMS [1]
(Cell-free assay)
ACK1 [1]
(Cell-free assay)
B-Raf (V600E) [1]
(Cell-free assay)
C-Raf [1]
(Cell-free assay)
MAP4K5 (KHS1) [1]
(Cell-free assay)
18 nM 19 nM 31 nM 48 nM 51 nM
体外研究

PLX4032抑制B-RAFV600E, C-RAF, 和 野生型B-RAF, IC50分别为31 nM, 48 nM, 和100 nM。PLX4032 也抑制一些非-RAF激酶,包括ACK1, KHS1,和SRMS, IC50 为18 nM 到51 nM。[1] PLX4032作用于黑色素瘤细胞系,抑制效果依赖于B-RAF突变状态,因为PLX4032有效抑制含B-RAFV600突变的细胞, 包括V600E, V600D, V600K, 和V600R, 但是对野生型或其他突变没有作用效果。PLX4032作用于MALME-3M, Colo829, Colo38, A375, SK-MEL28, 和A2058细胞时,IC50为20 nM 到 1 μM。0.1 μM 到30 μM PLX4032 也抑制MEK1/2 和ERK1/2磷酸化作用。[2] PLX4032高效作用于黑色素瘤的治疗 ,因为PLX4032有效抑制B-RAFV600E。PLX4032作用于结肠癌细胞,抑制B-RAF V600E导致 EGFR激活的快速回应,可用于补偿PLX4032抑制的细胞增殖。[3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
SKMEL19 NYrJZlA2TnWwY4Tpc44hSXO|YYm= M2n1dlYh|ryP NWXYSWNQPDhiaB?= MYnEUXNQ NYS2dnB7XHKrZ3fldpMhTVJic4Ty[ZN{ NGn4[3Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{O2NlI1OCd-MkOzOlIzPDB:L3G+
VMM12 NWGyR4t{TnWwY4Tpc44hSXO|YYm= NUTVbopVOyEQvF2= NHT3Soc1QCCq NX;6b41uTE2VTx?= MYXJcoNz\WG|ZYOgZ49tdGGpZX6gd5lvfGinc3nzJIFv\CCmZXPy[YF{\XNiSVytPUBmgHC{ZYPzbY9v MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTl6OUWwOkc,OjV7OEm1NFY9N2F-
C4 M{fvVGZ2dmO2aX;uJGF{e2G7 M1TUPFMh|ryP Mn\YOFghcA>? NVr0dIFQTE2VTx?= MknwTY5kemWjc3XzJINwdGyjZ3XuJJN6dnSqZYPpd{BidmRiZHXjdoVie2W|IFnMMVgh\XiycnXzd4lwdg>? MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTl6OUWwOkc,OjV7OEm1NFY9N2F-
Calu-6 MlTkSpVv[3Srb36gRZN{[Xl? NEe3VIwy6oDLzszN MkPFNUBp MWTEUXNQ MlTLRYN1cX[jdHXzJG1GUy:HUlugbY4h[2WubIOge4l1cCC5aXzkMZR6eGViQmLBSi=> M2\YV|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMUe5O|A2Lz5{MEG3PVcxPTxxYU6=
PC M4TnTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX\pOlBZQTZiaB?= NFPhXHlGSzVyPjCxNFAxKG6P M1yyN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OEiwO|kzLz5zOUi4NFc6OjxxYU6=
TPC-1 (RET/PTC1) M4q2W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHjR[ow6PiCq M1XqW2VEPTEkibWxNFAxKG6P M1jQc|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OEiwO|kzLz5zOUi4NFc6OjxxYU6=
CAL62 (KRAS G12R) > 1000 > 1000 NIDMUWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlLZPVYhcA>? MUXFR|UxRiBzMECwJI5O MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTh6MEe5Nkc,OTl6OEC3PVI9N2F-
HTH7 (NRAS Q61R) MonYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWHYenAzQTZiaB?= NHrKcnlGSzVy4polJFExODBibl2= MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTh6MEe5Nkc,OTl6OEC3PVI9N2F-
C643 (HRAS G13R)≥ 500 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUT3cJl2QTZiaB?= NE[5cGVGSzVyIPMJqUA2ODBibl2= MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTh6MEe5Nkc,OTl6OEC3PVI9N2F-
BCPAP (BRAF WT/V600E) Moi2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NG\Xb|Y6PiCq NIT6dppGSzVyPUe4JI5O NF[wUVA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUi4NFc6Oid-MUm4PFA4QTJ:L3G+
BHT101 (BRAF WT/V600E) MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1zPdlk3KGh? NYq5fIlOTUN3ME25O{BvVQ>? Mn;LQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl6OEC3PVIoRjF7OEiwO|kzRC:jPh?=
SW1736 (BRAF WT/V600E) MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXi5OkBp NF7JdZZGSzVyPUK5JI5O M2n6[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OEiwO|kzLz5zOUi4NFc6OjxxYU6=
8505C (BRAF V600E/V600E) MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVO5OkBp NXHDXVZ2TUN3ME21O{BvVQ>? NFKzfGY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUi4NFc6Oid-MUm4PFA4QTJ:L3G+
ARO MV3GeY5kfGmxbjDBd5NigQ>? MYKxNEDPxE1? M3HRelczKGh? MUTEUXNQ NH;DW4hKdmS3Y3XzJJRp\SC{ZXX4dJJme3Orb36gc4YhfGinIF7JV{BxfW2y M3;HTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEW4NFU{Lz5zOES1PFA2OzxxYU6=
A375 NV[5ZlZ{SXCxcITvd4l{KEG|c3H5 NU\0ZYRTOTBizszN MnnnSG1UVw>? NWXrcYFOWHKxbX;0[ZMh[XCxcITveIlkKGSnYYTo MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDR3OEC1N{c,OTh2NUiwOVM9N2F-
TPCI MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmrNNVAxKM7:TR?= MmDOPVYhcA>? NHXRUWxFVVOR MoPHTWM2OD1zMD63O{DPxE1? MnjvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh2NUiwOVMoRjF6NEW4NFU{RC:jPh?=
ARO M3r6bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV:xNFAh|ryP NF;4Rog6PiCq M1PhUGROW09? M3PORWlEPTB;MkC1JI5O MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDR3OEC1N{c,OTh2NUiwOVM9N2F-
NPA MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH:1NpkyODBizszN M17lO|k3KGh? NYHBdJNNTE2VTx?= Mn;TTWM2OD1{NjDuUS=> M3fueFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEW4NFU{Lz5zOES1PFA2OzxxYU6=
A375 NW\oRlVIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHKzUlIyODBizszN MlrPPVYhcA>? M3fVW2ROW09? NFrxTJFKSzVyPUS3JI5O NFHjcFY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOES1PFA2Oyd-MUi0OVgxPTN:L3G+
UKF-NB-3 (ABCB1) NUPj[lk5TnWwY4Tpc44hSXO|YYm= Mm[yNU4zPSEEtV2= NXSyU4lYOiCq NIjMR2JFVVOR Ml;mSY5p[W6lZYOgZYNkfW23bHH0bY9vKG:oIITo[UBndHWxcnXzZ4VvfCCDQlPCNUB{fWK|dILheIUhemixZHHtbY5mKDF{Mx?= M{XwSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{O1O|Y3Lz5{NEezOVc3PjxxYU6=
UKF-NB-3 MmrsSpVv[3Srb36gRZN{[Xl? NYT3cmRCOS5{NTFCuW0> Mnn1NkBp NXPsO|RbTE2VTx?= M2nIZXNq\26rZnnjZY51dHliYX\m[YN1eyCxbjDhZ4N2dXWuYYTpc44hd2ZidHjlJIZtfW:{ZYPj[Y51KEGEQ1KxJJN2[nO2cnH0[UBzcG:mYX3pcoUhOTJ| NH;wemY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEezOVc3Pid-MkS3N|U4PjZ:L3G+
A375 (BRAFV600E) Moq0SpVv[3Srb36gRZN{[Xl? Mn;BPEBp NEjkSWdFVVOR Mk\MTY5kemWjc3XzJIlvfHKjY3XscJVt[XJiUl;TJIFv\CCQTzDs[ZZmdHN? NXyxZms6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWzOlM3PDRpPkK1N|Y{PjR2PD;hQi=>
A375P MVjBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M13RfGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUO3OXAh[2WubIOsJGlEPTBiPTCwMlI2PCEQvF2u NV3TOFNyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK0OlAxOzBpPkKyOFYxODNyPD;hQi=>
A375 MYHBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NYPLNFdJSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBN|c2KGOnbHzzJIV5eHKnc4PpcochSi2UYX[gWlYxOEVibYX0ZY51KGGwZDD3bYxlKHS7cHWgVoF{NCCLQ{WwJF0hOC5|MTFOwG0v MoTuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ6MEi5NVEoRjJ{OEC4PVEyRC:jPh?=
A375P M{C3NmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 M2jxW|Q5KGi{cx?= MUnBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF|N{XQJINmdGy|IHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSByLkK1JO69VS5? M2ezOVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MUK4OFExLz5{NEGyPFQyODxxYU6=
A375 M3zUTmN6fG:2b4jpZ4l1gSCjc4PhfS=> MYm3NkBpenN? NV7JdmRpS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSTN5NTDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC5zODFOwG0v NGHl[pI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEKxOVgyQCd-MkSyNVU5OTh:L3G+
SK-MEL-28 MV\DfZRwfG:6aXPpeJkh[XO|YYm= MnXQR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gV2suVUWOLUK4JINmdGy|IHX4dJJme3OrbnegRk1z[WZiVk[wNGUhdXW2YX70MEBKSzVyIE2gNE4yKM7:TT6= MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDR5MUS2Okc,OjR2N{G0OlY9N2F-
M229 M165OGN6fG:2b4jpZ4l1gSCjc4PhfS=> MlvtR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUVIzQSClZXzsd{BmgHC{ZYPzbY5oKEJvcnHmJHY3ODCHIH31eIFvfCxiSVO1NEA:KDBwMTFOwG0v MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDR5MUS2Okc,OjR2N{G0OlY9N2F-
M263 M2\KU2N6fG:2b4jpZ4l1gSCjc4PhfS=> NG\sdnFEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOOjZ|IHPlcIx{KGW6cILld5NqdmdiQj3yZYYhXjZyMFWgcZV1[W62LDDJR|UxKD1iMD6xJO69VS5? NYXCSFRjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS0O|E1PjZpPkK0OFcyPDZ4PD;hQi=>
M321 NXKwU4NDS3m2b4TvfIlkcXS7IHHzd4F6 NYLKNoVYS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVTN{MTDj[YxteyCneIDy[ZN{cW6pIFKtdoFnKFZ4MEDFJI12fGGwdDygTWM2OCB;IECuNUDPxE1w M13ZdlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2NEexOFY3Lz5{NES3NVQ3PjxxYU6=
M238 M{\0U2N6fG:2b4jpZ4l1gSCjc4PhfS=> MXvDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNNlM5KGOnbHzzJIV5eHKnc4PpcochSi2{YX[gWlYxOEVibYX0ZY51NCCLQ{WwJF0hOC5zIN88UU4> NI\XNmM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NES3NVQ3Pid-MkS0O|E1PjZ:L3G+
M262 MWDDfZRwfG:6aXPpeJkh[XO|YYm= M1TRPGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG0zPjJiY3XscJMh\XiycnXzd4lv\yCELYLh[kBXPjByRTDteZRidnRuIFnDOVAhRSByLkGg{txONg>? NF3RdWw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NES3NVQ3Pid-MkS0O|E1PjZ:L3G+
M249 M4nYVWN6fG:2b4jpZ4l1gSCjc4PhfS=> MYHDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNNlQ6KGOnbHzzJIV5eHKnc4PpcochSi2{YX[gWlYxOEVibYX0ZY51NCCLQ{WwJF0hOC5zIN88UU4> MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDR5MUS2Okc,OjR2N{G0OlY9N2F-
M14 NV3xcVRPS3m2b4TvfIlkcXS7IHHzd4F6 NVWxN4ZJS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVTF2IHPlcIx{KGW6cILld5NqdmdiTmLBV{BIOTKFIH31eIFvfCxiSVO1NEA:KDBwMUWg{txONg>? NUDXblNGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS0O|E1PjZpPkK0OFcyPDZ4PD;hQi=>
SK-MEL-28 M321bmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MVu2PEBpenN? MmKzRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCVSz3NSWwuOjhiY3XscJMhcGG{Yn;ybY5oKEKUQV[gWlYxOEVibYX0ZY51KGGodHXyJFY5KGi{czDifUBOXFNiYYPzZZktKEmFNUCgQUAxNjR6IN88UU4> NWG1ZoZGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS1PFgxPzNpPkK0OVg5ODd|PD;hQi=>
insect cell M{jpNWZ2dmO2aX;uJIF{e2G7 NGHyS5I3OCCvaX7z MUDJcohq[mm2aX;uJI9nKG[3bHygcIVv\3SqIHj1cYFvKEJvUnHmJHY3ODCHIH31eIFvfCCneIDy[ZN{\WRiaX6gZoFkfWyxdnnyeZMhcW6oZXP0[YQhcW6|ZXP0JINmdGy|IHHzd4V{e2WmIHHzJHto[W2vYT2zN3BecW6lb4Lwc5JifGmxbjDpcpRwKE2HSzDh[pRmeiB4MDDtbY5{KGK7IIPjbY51cWyuYYTpc44h[2:3boTpcoctKEmFNUCgQUAxNjB|MTFOwG0v NULNUYdGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFA{OTVpPkK0PVAxOzF3PD;hQi=>
MALME-3M NHfxNlFHfW6ldHnvckBie3OjeR?= NYLIboltOSCqch?= M2LwT2lvcGmkaYTpc44hd2ZiQj3SZYYhXjZyMFWgcZV1[W62LX3l[IlifGWmIFXyb{BxcG:|cHjvdplt[XSrb36gbY4hcHWvYX6gUWFNVUVvM12gZ4VtdHNiYX\0[ZIhOSCqcjDifUBndHWxcnXzZ4Vv[2ViYX7hcJl{cXNuIFnDOVAhRSByLkC2NUDPxE1w MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEOxOUc,OjR7MECzNVU9N2F-
A375 M3PieGZ2dmO2aX;uJIF{e2G7 MUGxJIhz MkXxTY5pcWKrdHnvckBw\iCELWLh[kBXPjByRTDteZRidnRvbXXkbYF1\WRiRYLrJJBpd3OyaH;yfYxifGmxbjDpckBpfW2jbjDBN|c2KGOnbHzzJIFnfGW{IEGgbJIh[nliZnz1c5Jme2OnbnPlJIFv[Wy7c3nzMEBKSzVyIE2gNE4yQSEQvF2u NFH6eYo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEmwNFMyPSd-MkS5NFA{OTV:L3G+
COLO205 MmLsR5l1d3SxeHnjbZR6KGG|c3H5 NUjYN45{PCCmYYnz MVXDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDDU2xQOjB3IHPlcIx{KGGodHXyJFQh\GG7czDifUBE\WyuVHn0[ZIuT2yxIHHzd4F6NCCHQ{WwJF0hOC5{NDFOwG0v MoT2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7MECzNVUoRjJ2OUCwN|E2RC:jPh?=
WM266.4 NU\Pb2V[SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= M1XXN|Q5KGi{cx?= MVrBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFePMk[2MlQh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuNFYh|ryPLh?= MlP4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV{NkewNFYoRjJ3Mk[3NFA3RC:jPh?=
A375 NIPRZphCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NH\4UXc1QCCqcoO= NV\nTmM5SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBN|c2KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTCwMlE6KM7:TT6= NH\ie409[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUK2O|AxPid-MkWyOlcxODZ:L3G+
WM1361 NUPxUJlLSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NIHrV3U1QCCqcoO= MWHBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFePMUO2NUBk\WyuczDh[pRmeiB2ODDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iMT64O{DPxE1w M2PCPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3Mk[3NFA3Lz5{NUK2O|AxPjxxYU6=
A375 NG\mZpVHfW6ldHnvckBie3OjeR?= NWXRUmdQUW6qaXLpeIlwdiCxZjDCMZJi\iCYNkCwSUBufXSjboSgbY4hcHWvYX6gRVM4PSClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gSXJMOS9{IIDoc5NxcG:{eXzheIlwdiCrbnP1ZoF1\WRiZn;yJFkxKG2rboOgZpkhX2W|dHXyckBjdG:2dHnu[{Bu\XSqb3SsJGlEPTBiPTCwMlA{OzFizszNMi=> M2LxeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NE[yNlY4Lz5{NUS2NlI3PzxxYU6=
A375 NG[0R|ZCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= M1\rbFczKGi{cx?= NVTBTHhiSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBN|c2KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDDR2s5KGG|c3H5MEBKSzVyIE2gN{4{OTVizszNMi=> NGLsO|g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUS2NlI3Pyd-MkW0OlIzPjd:L3G+
SK-MEL-2 NV;MOZp[TnWwY4Tpc44h[XO|YYm= MlG5TY5pcWKrdHnvckBw\iC5aXzkJJR6eGViQj3yZYYhcW5iaIXtZY4hW0tvTVXMMVIh[2WubIOgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIFXST|EwOiCyaH;zdIhwenmuYYTpc44hcW6ldXLheIVlKG[xcjC5NEBucW6|IHL5JHdme3Sncn6gZoxwfHSrbnegcYV1cG:m MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTR4MkK2O{c,OjV2NkKyOlc9N2F-
A375 M2DZOWZ2dmO2aX;uJIF{e2G7 NInrdIQ4OiCqcoO= NE\5PFhKdmirYnn0bY9vKG:oIFLSRWYhXjZyMFWgcZV1[W62IHnuJIh2dWGwIFGzO|Uh[2WubIOgZZN{\XO|ZXSgZZMhcW6qaXLpeIlwdiCxZjDFVmsheGixc4Doc5J6dGG2aX;uJI1m[XO3cnXkJIFnfGW{IEeyJIhzeyCkeTDFUGlUSSCjc4PhfUwhUUN3MDC9JFAvOTVizszNMi=> NH7FTVI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUm2OVgxPCd-MkW5OlU5ODR:L3G+
A375 MmHwRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M1K2VFczKGi{cx?= M4O1b2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUO3OUBk\WyuczDh[pRmeiB5MjDodpMh[nlicnXzZZp2emmwIHHzd4F6NCCLQ{WwJF0hOC5zNzFOwG0v Ml2zQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV7NkW4NFQoRjJ3OU[1PFA1RC:jPh?=
A375 Mk\rSpVv[3Srb36gZZN{[Xl? NF7mdFcyPSCvaX7z NIDsb5NEd22yZYTpeIl3\SCkaX7kbY5oKGGoZnnubZR6KHSxIFLSRWYhcW5iaIXtZY4hSTN5NTDj[YxteyCjZoTldkAyPSCvaX7zJIlvKHC{ZYPlcoNmKG:oIFHUVEBidmGub3f1[UwhUUN3MDC9JFAvOjZizszNMi=> NXHxXZExRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW5OlU5ODRpPkK1PVY2QDB2PD;hQi=>
A375 MXnGeY5kfGmxbjDhd5NigQ>? MkfhNVUhdWmwcx?= NYK4SVc5S2:vcHX0bZRqfmViYnnu[Ilv\yCjZn\pcol1gSC2bzDBVmFHKGmwIHj1cYFvKEF|N{WgZ4VtdHNiYX\0[ZIhOTVibXnud{BqdiCycnXz[Y5k\SCxZjDBWHAh[W6jbH;neYUtKEmFNUCgQUAxNjl3IN88UU4> NVW3Zph7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW5OlU5ODRpPkK1PVY2QDB2PD;hQi=>
HCT116 M3rzUmZ2dmO2aX;uJIF{e2G7 MY\Jcohq[mm2aX;uJI9nKEuUQWOgS|E{TCCvdYThcpQhcW5iaIXtZY4hUEOWMUG2JINmdGy|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiRWLLJJBpd3OyaH;yfYxifGmxbjDifUBGVEmVQTygTWM2OCB;IEG2MlYh|ryPLh?= NEW0dYI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUm2OVgxPCd-MkW5OlU5ODR:L3G+
HCT116 NU\hSZZlTnWwY4Tpc44h[XO|YYm= MlnJNE4{PCC2bzCyNFAxOCCwTR?= NEWxOGpR[XKjZH;4bYNidCCjY4TpeoF1cW:wIH;mJHJCWy:UQV[vUWVMKHOrZ37hcIlv\yCyYYToe4F6KGmwIHj1cYFvKEiFVEGxOkBk\WyuczDlfJBz\XO|aX7nJJdqdGRidInw[UBDWkGIIHHzd4V{e2WmIHHzJGVTUyCyaH;zdIhwenmuYYTpc44h[XRiMD6zOEB1dyB{MECwNEBvVQ>? M3HxV|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OU[1PFA1Lz5{NUm2OVgxPDxxYU6=
NZM20 NHuxVGNCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MnTsOlghcHK| MlXpRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCQWl2yNEBk\WyuczDlfJBz\XO|aX7nJGIuWmGoIG[2NFBGKG23dHHueEBqe2:uYYTl[EBnem:vIF7le{Bb\WGuYX7kJI1mfGG|dHH0bYMhdWWuYX7vcYEheGG2aXXueEBqdmO3YnH0[YQh\m:{IE[4JIhzeyCkeTDTVmIh[XO|YYmsJGlEPTBiPTCwMlAzPCEQvF2u M{DXTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4MEC1OVMxLz5{NkCwOVU{ODxxYU6=
NZM07 Ml7XRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MkDTOlghcHK| M1PD[GFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTmrNNFch[2WubIOg[ZhxemW|c3nu[{BDNVKjZjDWOlAxTSCvdYThcpQhcXOxbHH0[YQh\nKxbTDO[ZchYmWjbHHu[EBu\XSjc4TheIlkKG2nbHHuc41iKHCjdHnlcpQhcW6ldXLheIVlKG[xcjC2PEBpenNiYomgV3JDKGG|c3H5MEBKSzVyIE2gNE4xOzZizszNMi=> NIX0N|Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkCwOVU{OCd-Mk[wNFU2OzB:L3G+
A375 Mn\RRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NEnOU4U3QCCqcoO= NX7EU3h{SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBN|c2KGOnbHzzJIV5eHKnc4PpcochSi2UYX[gWlYxOEVibYX0ZY51KGmwY4XiZZRm\CCob4KgOlghcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvODd7IN88UU4> NEG1XXQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkCwOVU{OCd-Mk[wNFU2OzB:L3G+
COLO205 M4rXTmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MVy2PEBpenN? MXjBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEORTF:yNFUh[2WubIOg[ZhxemW|c3nu[{BDNVKjZjDWOlAxTSCvdYThcpQhcW6ldXLheIVlKG[xcjC2PEBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gNE4{ODlizszNMi=> MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjByNUWzNEc,OjZyMEW1N|A9N2F-
SK-MEL-28 MVPBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NX65OXpEPjhiaILz NH:1bmNCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPLMW1GVC1{ODDj[YxteyCneIDy[ZN{cW6pIFKtVoFnKFZ4MEDFJI12fGGwdDDpcoN2[mG2ZXSg[o9zKDZ6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSByLkO4NUDPxE1w M2\KUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4MEC1OVMxLz5{NkCwOVU{ODxxYU6=
HT-29 NF7WWVhCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NWHFfmpqPjhiaILz MUPBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEiWLUK5JINmdGy|IHX4dJJme3OrbnegRk1T[WZiVk[wNGUhdXW2YX70JIlv[3WkYYTl[EBnd3JiNkigbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuOlAyKM7:TT6= NYnpboVoRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[wNFU2OzBpPkK2NFA2PTNyPD;hQi=>
SK-MEL-1 NF\SWWRCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= M3;aR|Y5KGi{cx?= NG\lTIVCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPLMW1GVC1zIHPlcIx{KGW6cILld5NqdmdiQj3SZYYhXjZyMFWgcZV1[W62IHnuZ5Vj[XSnZDDmc5IhPjhiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDFwNEm5JO69VS5? MmXhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZyMEW1N|AoRjJ4MEC1OVMxRC:jPh?=
NZM40 NEHaPW1CdnSrcILvcIln\XKjdHn2[UBie3OjeR?= M2rBUFY5KGi{cx?= NVTXPJJzSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDOXm01OCClZXzsd{BmgHC{ZYPzbY5oKHerbHSgeJlx\SCELWLh[kBqe2:uYYTl[EBnem:vIF7le{Bb\WGuYX7kJI1mfGG|dHH0bYMhdWWuYX7vcYEheGG2aXXueEBqdmO3YnH0[YQh\m:{IE[4JIhzeyCkeTDTVmIh[XO|YYmsJGlEPTBiPTCzMlAyKM7:TT6= NHv1V3g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkCwOVU{OCd-Mk[wNFU2OzB:L3G+
NZM09 NIn1WHhCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MmXtOlghcHK| NYntSJFXSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDOXm0xQSClZXzsd{BmgHC{ZYPzbY5oKHerbHSgeJlx\SCELWLh[kBqe2:uYYTl[EBnem:vIF7le{Bb\WGuYX7kJI1mfGG|dHH0bYMhdWWuYX7vcYEheGG2aXXueEBqdmO3YnH0[YQh\m:{IE[4JIhzeyCkeTDTVmIh[XO|YYmsJGlEPTBiPTC4MlM{KM7:TT6= NY\mdVQxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[wNFU2OzBpPkK2NFA2PTNyPD;hQi=>
A375P MYPBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NVnLN4JRPzJiaILz MlfDRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCDM{e1VEBk\WyuczDlfJBz\XO|aX7nJGJTSUZiVk[wNGUhdXW2YX70JIFnfGW{IEeyJIhzeyCkeTDD[YxtXGm2ZYKtS4xwKGG|c3H5MEBKSzVyIE2gNE4{PyEQvF2u MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjd{NEezNEc,OjZ5MkS3N|A9N2F-
BL21(DE3) MX7GeY5kfGmxbjDhd5NigQ>? M1rBXmlvcGmkaYTpc44hd2ZiTj30[ZJucW6jbDDobZMufGGpZ3XkJGJTSUZiVk[wNGUhdXW2YX70JEg1PDhidH:gO|I{KHKnc3nkeYV{MSBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDFd4Np\XKrY3jpZUBkd2yrIFLMNlEpTEV|KTDj[YxteyCjc4Pld5Nm\CCjczDwbI9{eGixconsZZRqd25ib3[gZolwfGmweXzheIVlNU2HSzDifUBCdHCqYWPjdoVmdiCjc4PhfUwhUUN3MDC9JFAvODNzIN88UU4> NGL3eXY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Nki1NlYzOyd-Mk[4OVI3OjN:L3G+
A375 M37FUGZ2dmO2aX;uJIF{e2G7 NY\hUZd6OSCqch?= NEXRWmVKdmirYnn0bY9vKG:oIFKtVoFnKFZ4MEDFJI12fGGwdDDpckBpfW2jbjDBN|c2KGOnbHzzJIF{e2W|c3XkJIF{KEWUSzDwbI9{eGixconsZZRqd25icILlbY5kfWKjdHXkJIZweiBzIHjyJIJ6KFenc4Tldo4h[myxdDDt[ZRpd2RuIFnDOVAhRSByLkCxO{DPxE1w M{P1b|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5MEi1OlczLz5{N{C4OVY4OjxxYU6=
MIAPaCa2 MVLGeY5kfGmxbjDhd5NigQ>? MkSwNUBpeg>? MnPkTY5pcWKrdHnvckBw\iC5aXzkJJR6eGViQj3SZYYhcW5iaIXtZY4hVUmDUHHDZVIh[2WubIOgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIFXST{BxcG:|cHjvdplt[XSrb36gdJJmcW6ldXLheIVlKG[xcjCxJIhzKGK7IGfld5Rmem5iYnzveEBu\XSqb3SsJGVEPTBiPTCyMlI6KM7:TT6= NVvhOXBnRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkewPFU3PzJpPkK3NFg2Pjd{PD;hQi=>
COLO205 M3u0ZWN6fG:2b4jpZ4l1gSCjc4PhfS=> NF6y[Zc4OiCqcoO= MYrDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDDU2xQOjB3IHPlcIx{KGijcnLvdolv\yCELWLh[kBXPjByRTDteZRidnRiYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36gZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuNFQ1KM7:TT6= NXG0eFhqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkexOVU5QTlpPkK3NVU2QDl7PD;hQi=>
HT-29 MWjDfZRwfG:6aXPpeJkh[XO|YYm= MUO3NkBpenN? MVvDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDIWE0zQSClZXzsd{Bp[XKkb4LpcochSi2UYX[gWlYxOEVibYX0ZY51KGG|c3Xzd4VlKGG|IHfyc5d1cCCrbnjpZol1cW:wIHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSByLkG1OkDPxE1w M{e2RVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5MUW1PFk6Lz5{N{G1OVg6QTxxYU6=
HCT116 MXvDfZRwfG:6aXPpeJkh[XO|YYm= MoTxO|IhcHK| NEjYV25EgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJS1RzMU[gZ4VtdHNiaHHyZo9zcW6pIIfpcIQhfHmyZTDCMXJi\iCjc4Pld5Nm\CCjczDndo94fGhiaX7obYJqfGmxbjDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iMUSuOVgh|ryPLh?= NETWbIk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{G1OVg6QSd-MkexOVU5QTl:L3G+
WM266.4 NE\YWmZCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NWGyO|FXOjRiaILz M1TYTWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iV12yOlYvPCClZXzsd{Bie3Onc4Pl[EBieyClZXzsJJZq[WKrbHn0fUBi\nSncjCyOEBpenNiYomgUXRVKGG|c3H5MEBIUTVyIE2gNE4zOSEQvF2u M{jxUVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5MkO4PFQyLz5{N{KzPFg1OTxxYU6=
WM266.4 NFHiXmpCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MmjKNlQhcHK| NI\QbGxCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGfNNlY3NjRiY3XscJMhcGG{Yn;ybY5oKEKUQV[gWlYxOEVibYX0ZY51KGG|c3Xzd4VlKGG|IHPlcIwh\3Kxd4ToJIlvcGmkaYTpc44h[W[2ZYKgNlQhcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvODdizszNMi=> NILzem89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{[zOFE6PSd-Mke2N|QyQTV:L3G+
A375 NEf4NI1CdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MYiyOEBpenN? Ml3LRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCDM{e1JINmdGy|IHHzd4V{e2WmIHHzJINmdGxiZ4Lve5RpKGmwaHnibZRqd25iYX\0[ZIhOjRiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDBwMkGg{txONg>? MlWzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd4M{SxPVUoRjJ5NkO0NVk2RC:jPh?=
WM1361 NFPaWIlCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NVu0cpR{OjRiaILz Mof3RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCZTUGzOlEh[2WubIOgZZN{\XO|ZXSgZZMh[2WubDDndo94fGhiaX7obYJqfGmxbjDh[pRmeiB{NDDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iMT64OkDPxE1w MoLXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd4M{SxPVUoRjJ5NkO0NVk2RC:jPh?=
SK-MEL-28 MUTBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? Mn;jOFghcHK| M3H6[2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU1utUWVNNTJ6IHPlcIx{KGijcnLvdolv\yCEUlHGJHY3ODCHIH31eIFvfCCjc4Pld5Nm\CCjczDjc45k\W62cnH0bY9vKHKncYXpdoVlKG[xcjD0c5RidCCpcn;3eIghcW6qaXLpeIlwdiCvZXHzeZJm\CCjZoTldkA1QCCqcoOgdoV{[Xq3cnnuJIF{e2G7LDDUS2khRSB{IN88UU4> NVPnSFk6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke3O|QyOzdpPkK3O|c1OTN5PD;hQi=>
SK-MEL-28 NYPHfWVjT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= Mon6NUBpeg>? M{WwWWdzd3e2aDDpcohq[mm2aX;uJI9nKGi3bXHuJHNMNU2HTD2yPEBk\WyuczDoZZJjd3KrbnegRnJCTiCYNkCwSUBufXSjboSgdJJmcW6ldXLheIVlKG[xcjCxJIhzKG[xbHzve4VlKGK7IHnydoFlcWG2aX;uJI9nKDFwMUOgb3cwdTJiVW[tcIlocHRiZn;yJFUhdWmwczDt[YF{fXKnZDDh[pRmeiB2ODDodpMhemW|YYr1dolvKGG|c3H5 NXvPZ2d3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke3O|QyOzdpPkK3O|c1OTN5PD;hQi=>
A375 NFnOPJNCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NVTYdJdkPzJiaILz NHTqOZZCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBpfW2jbjDBN|c2KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDj[YxtKHSrdHXyMYdtdyCudX3pcoV{[2WwY3WgZZN{[XluIFnDOVAhRSByLkeg{txONg>? NYDpOIpbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkiyOFI2PTNpPkK4NlQzPTV|PD;hQi=>
COLO205 NXvRSlFvSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MkCwO|IhcHK| MUPBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDoeY1idiCFT1zPNlA2KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDj[YxtKHSrdHXyMYdtdyCudX3pcoV{[2WwY3WgZZN{[XluIFnDOVAhRSB3LkG2JO69VS5? MnzLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{NEK1OVMoRjJ6MkSyOVU{RC:jPh?=
HepG2 MnrxRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M135V|czKGi{cx?= NVH5fYVFSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkhcHWvYX6gTIVxTzJiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JINmdGxidHn0[ZIu\2yxIHz1cYlv\XOlZX7j[UBie3OjeTygTWM2OCB;IEWuOFgh|ryPLh?= NXX4enN[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkiyOFI2PTNpPkK4NlQzPTV|PD;hQi=>
SK-MEL-2 M4mxTGFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NHj0e4g4OiCqcoO= MoXtRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgbJVu[W5iU1utUWVNNTJiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JINmdGxidHn0[ZIu\2yxIHz1cYlv\XOlZX7j[UBie3OjeTygTWM2OCB;IEWuOlQh|ryPLh?= Mnz4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{NEK1OVMoRjJ6MkSyOVU{RC:jPh?=
K562 NIrIZlRHfW6ldHnvckBie3OjeR?= M4L2VFEhcHJ? MlvsV5Ri[mmuaYrheIlwdiCxZjDCVmFHKGmwIHj1cYFvKEt3NkKgZ4VtdHNiYX\0[ZIhOSCqcjDifUB1cGW{bXHsJJNpcW[2IHHzd4F6NCCHQ{WwJF0hOC55OUSzN{DPxE1w NInzN409[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEK4NFI3OSd-MkiyPFAzPjF:L3G+
K562 M4m5bWZ2dmO2aX;uJIF{e2G7 MlHqNUBpeg>? MX;TeIFjcWyrenH0bY9vKG:oIF\FR2ghcW5iaIXtZY4hUzV4MjDj[YxteyCjZoTldkAyKGi{IHL5JJRp\XKvYXygd4hq\nRiYYPzZZktKEWFNUCgQUA2NjBzMUi3JO69VS5? MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDJ6MEK2NUc,Ojh{OECyOlE9N2F-
A375M MVHBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MWC3NkBpenN? NYPsdXRLSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBN|c2VSClZXzsd{Bp[XKkb4LpcochSlKDRjDWOlAxTSCvdYThcpQh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvPSEQvF2u MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDR3OEGzOEc,Ojh2NUixN|Q9N2F-
1205 Lu MXzBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? Mn\nO|IhcHK| MUfBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKDF{MEWgUJUh[2WubIOgbIFz[m:{aX7nJGJTSUZiVk[wNGUhdXW2YX70JIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTCyJO69VS5? MoDJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh2NUixN|QoRjJ6NEW4NVM1RC:jPh?=
A375M MYPBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MV:0PEBpenN? NHfyOJNCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFGzO|VOKGOnbHzzJIhiemKxcnnu[{BDWkGIIG[2NFBGKG23dHHueEBi\nSncjC0PEBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gNk4xPSEQvF2u NEXiPGc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OES1PFE{PCd-Mki0OVgyOzR:L3G+
UACC-903 M1ywWGFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MYC3NkBpenN? MmLORY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCXQVPDMVkxOyClZXzsd{Bp[XKkb4LpcochSlKDRjDWOlAxTSCvdYThcpQh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFIvPyEQvF2u MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDR3OEGzOEc,Ojh2NUixN|Q9N2F-
1205 Lu MWPBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NVT0bJpNPDhiaILz NGHTPYVCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIEGyNFUhVHViY3XscJMhcGG{Yn;ybY5oKEKUQV[gWlYxOEVibYX0ZY51KGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUA4NjZizszNMi=> M3LIb|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NEW4NVM1Lz5{OES1PFE{PDxxYU6=
UACC-903 M{\DZ2FvfGmycn;sbYZmemG2aY\lJIF{e2G7 MV[0PEBpenN? M4XCb2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVVHDR{06ODNiY3XscJMhcGG{Yn;ybY5oKEKUQV[gWlYxOEVibYX0ZY51KGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAyOi5|IN88UU4> M2LuTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NEW4NVM1Lz5{OES1PFE{PDxxYU6=
CHL-1 M3HM[GFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NXnrSo91PzJiaILz Mn:4RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCFSFytNUBk\WyuczDoZZJjd3Krbnege4lt\CC2eYDlJGJTSUZiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDF{Lkeg{txONg>? MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDR3OEGzOEc,Ojh2NUixN|Q9N2F-
CHL-1 MmnURY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M4nvfVQ5KGi{cx?= M{CwZWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQ1jMMVEh[2WubIOgbIFz[m:{aX7nJJdqdGRidInw[UBDWkGIIHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSB{MDFOwG0v NGHufmE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OES1PFE{PCd-Mki0OVgyOzR:L3G+
HCT116 NXO0cFFITnWwY4Tpc44h[XO|YYm= NGXrTXNUfGmvdXzheIlwdiCxZjDCVmFHNUOUQV[g[Ilu\XKrenH0bY9vKGmwIHj1cYFvKEiFVEGxOkBk\WyuczDifUBtfWOrZnXyZZNmKGOxbYDs[Y1mdnSjdHnvckBie3OjeTygSWM2OCB;IECuOlAyKM7:TT6= MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDV3N{S1PEc,Ojh3NUe0OVg9N2F-
Calu6 NXvFTXl1TnWwY4Tpc44h[XO|YYm= NXu2R4kzOyC3TR?= MnvMNkBpenN? MXvBZ5RqfmG2aX;uJI9nKEOUQV[gbY4hcHWvYX6gR4FtfTZiY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gUWVMKHCqb4PwbI9zgWyjdHnvckBifCB|IIXNJIFnfGW{IEKgbJJ{KGK7IF\SSXQh[XO|YYm= NX7mbmhSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki1OVc1PThpPkK4OVU4PDV6PD;hQi=>
Sf9 M2Ho[2Z2dmO2aX;uJIF{e2G7 M3HYelEhcHJ? M{HL[mlvcGmkaYTpc44hd2ZiaIXtZY4hYkGNIDi1JJRwKDNyOTDy[ZNq\HWnczmg[ZhxemW|c3XkJIlvKGKjY4Xsc5ZqenW|IHnu[oVkfGWmIGPmPUBqdnOnY4SgZ4VtdHNidYPpcochYkGNdHnk[UBieyC|dXLzeJJifGViYX\0[ZIhOSCqcjDifUBu[XO|IIPw[YN1em:vZYTyfUwhUUN3MDC9JFAvODJ|IN88UU4> MmTYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh3OE[yNVEoRjJ6NUi2NlEyRC:jPh?=
Sf9 NUfMeJpxTnWwY4Tpc44h[XO|YYm= NHjjZ3Y{OCCvaX7z M3\pdWlvcGmkaYTpc44hd2ZiTj30[ZJucW6jbDDHV3QufGGpZ3XkJJJm[2:vYnnuZY51KGi3bXHuJIZ2dGxvbHXu[5RpKFqDSzDlfJBz\XO|ZXSgbY4h[mGldXzveolzfXNiaX7m[YN1\WRiU3[5JIlve2WldDDj[YxteyC3c3nu[{BOSlBiYYOgd5Vje3S{YYTlJIFnfGW{IEOwJI1qdnNiYomgRWRRNUeubzDhd5NigSxiSVO1NEA:KDBwMEOxOEDPxE1w NGC1WYg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEW4OlIyOSd-Mki1PFYzOTF:L3G+
UACC-903 NH:wOYhEgXSxdH;4bYNqfHliYYPzZZk> MX[yOUB2VQ>? NGOyT401QCCqcoO= M3TINmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHVCS0NvOUCzJINmdGy|IHHzd4V{e2WmIHHzJINmdGxidnnhZoltcXS7IHH0JFI2KHWPIHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XlicnXsZZRqfmVidH:gZ49vfHKxbDygTWM2OCB;IEOuOkDPxE1w NX25SGZuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkmxN|MxOzVpPkK5NVM{ODN3PD;hQi=>
CHL-1 NVfEXXI5SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NHnaTXE4OiCqcoO= NH;VOZNCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFPIUE0yKGOnbHzzJIhiemKxcnnu[{B4cWymIIT5dIUhSlKDRjDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iMUOuO{DPxE1w MlvrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjlzM{OwN|UoRjJ7MUOzNFM2RC:jPh?=
A375 M13WVWZ2dmO2aX;uJIF{e2G7 NYK0dGZnQTZiaILz NXXyeogyUW6qaXLpeIlwdiCxZjDCVmFHKFZ4MEDFJI12fGGwdDDpckBpfW2jbjDBN|c2KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDj[YxtKHC{b3zp[oVz[XSrb36gbY5kfWKjdHXkJIZweiB7NjDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iMD6xNlch|ryPLh?= NH7uZ2o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSwO|k4Pyd-Mkm0NFc6Pzd:L3G+
A375 M4PkdWZ2dmO2aX;uJIF{e2G7 MWfJcohq[mm2aX;uJI9nKEKUQV[gWlYxOEVibYX0ZY51KGmwIHj1cYFvKEF|N{WgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKEWUSzDwbI9{eGixconsZZRqd25iYomgRYxxcGGVY4Ll[Y4h[XO|YYmsJGlEPTBiPTCwMlA{OiEQvF2u NH7MPII9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUS2NVgzPyd-Mkm0OlE5Ojd:L3G+
SK-MEL-32 NHTkcpZEgXSxdH;4bYNqfHliYYPzZZk> NVLobFVlS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hW0tvTVXMMVMzKGOnbHzzMEBKSzVyIE2gNE4{OSEQvF2u NUXWd5VSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0OlE5OjdpPkK5OFYyQDJ5PD;hQi=>
WM266.4 NIPwOVhCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MXi0PEBpenN? NFPiRmJCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGfNNlY3NjRiY3XscJMh[W[2ZYKgOFghcHK|IHL5JG1VXCCjc4PhfUwhT0l3MDC9JFAvOjFizszNMi=> NVjPVYY4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm5OFA1PjNpPkK5PVQxPDZ|PD;hQi=>
A375 M{f0TmFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NX[0cZZ{PDhiaILz NFzXUZhCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFGzO|Uh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IF3UWEBie3OjeTygS2k2OCB;IECuPVUh|ryPLh?= MkPnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl7NEC0OlMoRjJ7OUSwOFY{RC:jPh?=
HT-29 NHv2NHFCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= Mn[2OFghcHK| NUfVfFFtSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIWE0zQSClZXzsd{Bi\nSncjC0PEBpenNiYomgUXRVKGG|c3H5MEBIUTVyIE2gNU45QCEQvF2u NHnROW09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUm0NFQ3Oyd-Mkm5OFA1PjN:L3G+
WM1361 NUXvZXpZSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= M1\r[VQ5KGi{cx?= M1yxOWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iV12xN|YyKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO|YYmsJGdKPTBiPTCyNE45KM7:TT6= MkLkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl7NEC0OlMoRjJ7OUSwOFY{RC:jPh?=
HCT116 NEDSOXpCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NH61NYo1QCCqcoO= NYrxZ4RPSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIR3QyOTZiY3XscJMh[W[2ZYKgOFghcHK|IHL5JG1VXCCjc4PhfUwhT0l3MDC9JFI2NjJizszNMi=> MkHiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl7NEC0OlMoRjJ7OUSwOFY{RC:jPh?=
A673 MX\xTHRUKGG|c3H5 MYLxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSTZ5MzDj[Yxtew>? NFLNNoM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
DAOY MlfLdWhVWyCjc4PhfS=> NGq3VXNyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiRFHPXUBk\Wyucx?= M3n1bFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
RD MmDpdWhVWyCjc4PhfS=> MW\xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWkRiY3XscJM> MkPuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SK-N-SH MXzxTHRUKGG|c3H5 MonGdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFONLV6tV2gh[2WubIO= MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
MG 63 (6-TG R) NWPMRnZ5eUiWUzDhd5NigQ>? MYPxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhVUdiNkOgLFYuXEdiUjmgZ4VtdHN? M4j5PFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
NB1643 M1X4ZZFJXFNiYYPzZZk> M2LReZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCQQkG2OFMh[2WubIO= MkT0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
OHS-50 MXPxTHRUKGG|c3H5 NF6xUYtyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiT1jTMVUxKGOnbHzz MnXaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
A673 MUHxTHRUKGG|c3H5 NFj6W5RyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCFb37mbZJu[XSxcomgd4Nz\WWwIH\vdkBCPjd|IHPlcIx{MQ>? MnHTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
U-2 OS MoDTdWhVWyCjc4PhfS=> NXqzcI5ZeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiQ3;u[olzdWG2b4L5JJNkemWnbjDmc5IhXS1{IF;TJINmdGy| M3vETFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
Rh41 M3nGepFJXFNiYYPzZZk> NWWwV49EeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiQ3;u[olzdWG2b4L5JJNkemWnbjDmc5IhWmh2MTDj[Yxtew>? MlLXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SJ-GBM2 MU\xTHRUKGG|c3H5 M3rx[JFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSj3HRm0zKGOnbHzz NGXOZnY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SK-N-MC NW\jS4JseUiWUzDhd5NigQ>? MVfxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucx?= Ml;pQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
LAN-5 MmTPdWhVWyCjc4PhfS=> MUDxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhVEGQLUWgZ4VtdHN? MlLXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SK-N-MC M3i1ZpFJXFNiYYPzZZk> Mo\idWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohS2:wZnnycYF1d3K7IIPjdoVmdiCob4KgV2suVi2PQzDj[Yxtew>? NVzwfG54RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
TC32 NHPlXIhyUFSVIHHzd4F6 MX\xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBEd26oaYLtZZRwenlic3Py[YVvKG[xcjDUR|MzKGOnbHzz MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
p-ERK / p-CRAF; 

PubMed: 22448344     


BRAF mutant cell lines from (A) were treated with 3µM vemurafenib for the indicated times, and lysates were probed with the indicated antibodies.

p-MEK(S217/221) / pAKT(T308) / p-AKT(S473) / p-P70 S6K(T389) / p-S6(Ser235-236) / P-4EB-P1; 

PubMed: 22194965     


Western blot analysis of phosphorylated and the total amount of key proteins in the MAPK and PI3K/AKT pathways after 24 hours of exposure to the solvent (DMSO), or various concentrations of the BRAF inhibitor vemurafenib. The vemurafenib-sensitive M238 and M229 cell lines and the vemurafenib in vitro acquired resistant sublines M238-AR2 and M229-AR9 were cultured at different concentrations of vemurafenib. p70 and p-p70 S6K in this figure are referred to S6K1 and phosphorylated form of S6K1, respectively.

Bax / Bcl2 / Bcl-xl / BIM / Mcl1; 

PubMed: 28382170     


Change of Bcl-2 family proteins following Vemurafenib treatment for 24 h.

22448344 22194965 28382170
Growth inhibition assay
Cell viability; 

PubMed: 29179510     


At different time point of the experiment (expressed in days), sensitivity to vemurafenib was evaluated in the different A375 cell lines. Cells were treated with 10-fold dilution series (1 nM to 10 uM) of Vemurafenib and cell viability was assessed after 72 h by Crystal violet staining. Cell viability results are expressed in fold vs. the untreated cells.

29179510
Immunofluorescence
uPAR / α5-β1; 

PubMed: 30611716     


Representative images of confocal microscopy of companion M6R treated cultures stained with specific anti-uPAR (red), α5β1 (green) and DAPI (blue). Experiments have been performed three times in triplicate with analogous results. The co-localization score is quantified by image J andreported within each picture as Manders' coefficient (MC). The shown pictures are representative of 20 different pictures for each experimental condition. Scale bar = 20 μm.

p-Akt(Thr308); 

PubMed: 27293997     


Vemurafenib reduced phosphorylated Akt in HUVEC. Cells were treated with vemurafenib for 4 h and processed for immunofluorescence staining with antibodies against p-AktThr308. Cell nuclei were stained with DAPI. Scale bar represents 50 μm. 

30611716 27293997
体内研究 PLX4032按6 mg/kg-20 mg/kg 剂量作用于B-RAFV600E-突变鼠移植瘤模型,抑制肿瘤生长。[1] PLX4032按12.5 mg/kg-100 mg/kg剂量作用于携带LOX, Colo829, 和A375移植瘤小鼠,抑制肿瘤生长,延长小鼠寿命。[2]

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

激酶实验:

[1]

- 合并

RAF激酶活性测定:

通过测量生物素化的BAD蛋白磷酸化而测定野生型RAF和突变型的激酶活性。在20 mM Hepes (pH 7.0), 10 mM MgCl2, 1 mM DTT, 0.01% (v/v) Tween-20, 50 nM 生物素-BAD 蛋白,和 1 mM ATP 的混合物中室温下进行反应。加入5 μL 含20 mM Hepes (pH 7.0), 200 mM NaCl, 80 mM EDTA, 0.3% (w/v) 牛血清蛋白 (BSA)的溶液,5分钟后,反应终止。终止溶液也包含p-BAD (Ser112) 抗体,链霉亲和素包被的供体小珠,蛋白A 受体小珠。抗体和小珠在终止溶液中黑暗环境下室温预温育30分钟。 最终抗体被稀释2000倍,每个小珠的终浓度为10 μg/mL。重复做三次单独纯化蛋白实验,去不同两批的平均值作为突变活性。
细胞实验:

[2]

- 合并
  • Cell lines: MALME-3M, Colo829, Colo38, A375, SK-MEL28, 和 A2058 细胞
  • Concentrations: 0–10 μM , 溶于 DMSO
  • Incubation Time: 5 天
  • Method:

    通过MTT 实验测评细胞增殖。细胞按每孔1000到5000个接种在96孔板上,体积为180 μL。PLX4032按最终实验浓度的10倍储备在含1% DMSO的培养基中。细胞接种24小时后, 加入20 μL适当稀释的PLX4032。接种6天后,进行增殖实验。计算抑制百分数,根据抑制百分数与浓度的对数的回归分析测定IC50值。


    (Only for Reference)
动物实验:

[2]

- 合并
  • Animal Models: 携带LOX, Colo829, 和A375移植瘤细胞的无胸腺裸鼠
  • Dosages: 12.5 mg/kg–100 mg/kg
  • Administration: 口服饲喂,每天两次
    (Only for Reference)

溶解度 (25°C)

体外 DMSO 97 mg/mL (197.99 mM)
Water Insoluble
Ethanol Insoluble
体内 从左到右依次将纯溶剂加入产品,现配现用(数据来自Selleck实验检测而非文献):
4% DMSO+30% PEG 300+5% Tween 80+61% ddH2O
1.25mg/mL

* 溶解度检测是由Selleck技术部门检测的,可能会和文献中提供的溶解度有所差异,这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据

分子量 489.92
化学式

C23H18ClF2N3O3S

CAS号 918504-65-1
储存条件 粉状
溶于溶剂
别名 RG7204, RO5185426

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % ddH2O
计算重置

计算器

摩尔浓度计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

  • 质量
    浓度
    体积
    分子量

*在配置溶液时,请务必参考Selleck产品标签上、MSDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。

稀释计算器

稀释计算器

用本工具协助配置特定浓度的溶液,使用的计算公式为:

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入 输出 )

  • C1
    V1
    C2
    V2

在配置溶液时,请务必参考Selleck产品标签上、MSDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。.

连续稀释计算器方程

  • 连续稀释

  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量计算器

分子量计算器

通过输入化合物的化学式来计算其分子量:

总分子量:g/mol

注:化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量 浓度 体积 分子量
计算

临床试验信息

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT03013491 Active not recruiting Drug: CX-072|Drug: ipilimumab|Drug: vemurafenib Solid Tumor|Lymphoma CytomX Therapeutics January 2017 Phase 1|Phase 2
NCT02441465 Completed Drug: Vemurafenib|Drug: 14C-Labeled Vemurafenib Malignant Melanoma Cancer Hoffmann-La Roche August 13 2015 Phase 1
NCT02427893 Withdrawn Drug: Cobimetinib|Drug: Vemurafenib Melanoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Genentech Inc. August 2015 Phase 3
NCT02036086 Active not recruiting Drug: Vemurafenib|Drug: Cobimetinib Melanoma Sunnybrook Health Sciences Centre August 2015 Phase 2
NCT02456701 Completed Biological: KTN3379|Drug: vemurafenib Thyroid Cancer Celldex Therapeutics|Memorial Sloan Kettering Cancer Center June 2015 Phase 1
NCT02304809 Active not recruiting Drug: Vemurafenib Solid Tumors|Hematologic Cancers|Metastatic Cancers UNICANCER|National Cancer Institute France|Fondation ARC|Hoffmann-La Roche October 13 2014 Phase 2

技术支持

在订购、运输、储存和使用我们的产品的任何阶段,您遇到的任何问题,均可以通过拨打我们的热线电话400-668-6834,或者技术支持邮箱tech@selleck.cn,直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题,请给我们留言。

  • * 必填项

常见问题及建议解决方法

  • 问题 1:

    How about the half-life of Vemurafenib(S1267)?

  • 回答:

    It was reported that the half-life of the compound is 57 hours.

  • 问题 2:

    The vemurafenib power, when prepared in 4% DMSO/30% PEG 300/5% Tween 80/ddH2O solutions, form a pellet down the tube?

  • 回答:

    When prepare this kind of vehicle, please dissolve the drug in DMSO clearly first. If it dissolves not readily, please sonicate and warm in the water bath at about 45 degree. Then add PEG and Tween. After they mixed homogeneously, then dilute with water.

Raf Signaling Pathway Map

Raf Inhibitors with Unique Features

相关Raf产品

Tags: 购买Vemurafenib (PLX4032) | Vemurafenib (PLX4032)供应商 | 采购Vemurafenib (PLX4032) | Vemurafenib (PLX4032)价格 | Vemurafenib (PLX4032)生产 | 订购Vemurafenib (PLX4032) | Vemurafenib (PLX4032)代理商
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID